Cargando…
Long-term L-Carnitine Administration reduces Erythropoietin Resistance in Chronic Hemodialysis Patients with Thalassemia Minor
BACKGROUND AND AIM: Both thalassemia and carnitine deficiency represent independent causes of erythropoietin resistance, and thus anemia, in uremic patients. We evaluated the unknown long-term effects of L-carnitine administration in β-thalassemic on chronic hemodialysis. METHODS: We studied twelve...
Autores principales: | Di Iorio, Biagio R., Guastaferro, Pasquale, Cillo, Nicola, Cucciniello, Emanuele, Bellizzi, Vincenzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3155231/ https://www.ncbi.nlm.nih.gov/pubmed/21901057 |
Ejemplares similares
-
Lanthanum carbonate is not associated with QT interval modification in hemodialysis patients
por: Di Iorio, Biagio, et al.
Publicado: (2010) -
Effects of the route of erythropoietin administration on hemoglobin variability and cardiovascular events in hemodialysis patients
por: Kim, Do Hyoung, et al.
Publicado: (2021) -
Oral Zinc Supplementation Reduces the Erythropoietin Responsiveness Index in Patients on Hemodialysis
por: Kobayashi, Hiroki, et al.
Publicado: (2015) -
Kinetics of carnitine concentration after switching from oral administration to intravenous injection in hemodialysis patients
por: Suzuki, Anna, et al.
Publicado: (2018) -
Effects of switching from oral administration to intravenous injection of l-carnitine on lipid metabolism in hemodialysis patients
por: Fukami, Kei, et al.
Publicado: (2014)